Gorgone G, Spina F, Amantia L
Ophthalmologica. 1983;187(3):171-3. doi: 10.1159/000309320.
The authors studied the pressure-reducing action of a new beta-blocking agent (carteolol) in a group of subjects affected with open angle glaucoma. The drug was efficacious in all cases treated and did not show any noteworthy side effects.
作者们研究了一种新型β受体阻滞剂(卡替洛尔)对一组开角型青光眼患者的降压作用。该药物在所有接受治疗的病例中均有效,且未显示出任何明显的副作用。